Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
2 February 2017
Header
Header image
News

News

EFPIA statement on the ENVI Committee’s Report on Access to Medicines
01 February 2017

EFPIA notes yesterday’s adoption of the INI report by the European Parliament's Committee on Environment, Public Health and Food Safety (ENVI) on EU options for improving access to [...] Read more

Events calendar

Events Calendar

DIA BioVenture Day
On 28/03/2017 (Glasgow, UK)

DIA is excited to convene its 1st BioVenture Day, in a unique format with the participation of a very broad set of senior healthcare stakeholders. You will be able to explore whether the current BioVenture paradigm is delivering returns for patients, investors, and the healthcare system.

Read more

Events Calendar

DIA EuroMeeting 2017
From 29/03/2017 to 31/03/2017 (Glasgow, UK)

The DIA EuroMeeting 2017 is unique in presenting the entire healthcare microcosm, ranging from policy and regulations, to R&D marketing and access.

In an intense and stimulating three days, you will enjoy learning and debating. You will meet not only people you know, but also those that you want to know and those that you should know.

The DIA EuroMeeting allows you to debate the issues across the entire drug development value chain during the conference, and find solutions within the exhibition with 2,500+ other cross-functional thought leaders.

You will hear the latest solutions and challenges in healthcare. You will have plenty of opportunities to network and build relationships with trend-setters in e.g. the areas of regulatory science, clinical research and operations, value demonstration leads and patient advocates. The resulting knowledge transfer and lasting partnerships will reduce the burden of regulatory barriers, benefiting your business now and further down the line.

Read more

Events Calendar

6th FIP Pharmaceutical Sciences World Congress 2017: Future Medicines For One World
From 21/05/2017 to 24/05/2017 (Stockholm, Sweden)

Systems approaches to drug discovery, development and clinical usage

Join leading pharmaceutical scientists from around the world to discuss cutting-edge research and promising developments. 

Stockholm, Sweden. An exciting venue in which the leading pharmaceutical scientists from across the globe will meet to discuss the medicines of the future. What will be the breakthroughs and the pitfalls? How can we meet the biggest challenges?

The International Pharmaceutical Federation (FIP) is pleased to bring you the 6th PSWC, sponsored by many of the world’s leading pharmaceutical science and educational organisations.

To access the programme, click here.

Read more

Events Calendar

Certificate in Healthcare Compliance Ethics & Regulation
From 06/06/2017 to 09/06/2017 (Paris, France)

The Certificate in Healthcare Compliance Ethics & Regulation has been designed for Compliance Officers and Compliance Managers and Lawyers. It presents European and International Laws in the Health and Life Sciences Sector to provide a thorough understanding of the current stakes of the industry and increase participants’ knowledge and skills. Participants from all over the world will be immersed during a whole week into the legal framework of healthcare industries. They will discuss industry codes and work on cases and settlements with world-renown professionals. Organised with Seton Hall Law School, this program also takes place in the United Sates at Seton Hall Law School, Newark, NJ and in Singapore.

Audience: Compliance Officers and Compliance Managers from Pharmaceutical, Medical Device and Biotech Companies,  Lawyers representing the Health and Life Sciences Industry and Consultants to the Health and Life Sciences Industry

Purposes: Provide participants with in​-​depth knowledge of European and International Laws and Regulation,  Deepen the Understanding of how Ethics Codes are implemented and applied within the industry, Study Compliance Program and Cases to increase Awareness of Best Practices, and Apply this Legal Framework through Case Studies

Read more

What we are reading

What we are reading

Press release: CHEM21 method could dramatically cut production costs of essential anti-fungal medicine
02 February 2017 (IMI)

Scientists from the Innovative Medicines Initiative (IMI) project CHEM21 have developed a new, more efficient way of producing flucytosine, a medicine used to treat a common and often deadly fungal form of meningitis in people with HIV / AIDS. The new method, which is described in a paper in Organic Process Research & Development (OPR&D), is expected to decrease drastically costs of production, and so make the medicine more affordable for the many people with HIV/AIDS who live in low income countries. The CHEM21 team is now working to scale up the method to the industrial scale.

Read more

What we are reading

Health Programme - Annual work plan for 2017
02 February 2017 (European Commission)

The Annual Work Programme 2017 of the Health Programme was adopted on 26 January 2017.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail